ICR researchers discover use of ibrutinib drug to attack oesophageal cancer cells

Scientists from the UK Institute of Cancer Research (ICR) have identified an existing drug, ibrutinib, which could be effective against oesophageal cancers.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news